Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05563714 · ClinicalTrials.gov registry record · NA
Anticoagulation With Enhanced Gastrointestinal Safety
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 341
- Enrollment target
NCT05563714: Completed NA study, sponsored by University of Michigan.
NCT05563714 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 341 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05563714, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 341 participants
- Enrollment target
Study Summary
This study is a pragmatic cluster randomized controlled trial to evaluate the effectiveness of a clinician-facing implementation strategy on the use of medication optimization (defined as either discontinuation of all antiplatelet therapy or initiation of and adherence to a proton pump inhibitor (PPI)) to reduce upper GI bleeding risk in patients prescribed anticoagulant-antiplatelet therapy (AAT) relative to usual care.
Primary Outcome
The percent of patients reporting medication optimization is defined as the number of patients who either discontinue all antiplatelet medications (none in the past 7 days) or initiate and adhere to a proton pump inhibitor (PPI) (use for at least 5 of the prior 7 days) based on self-report at week 7-10 divided by the total number of patients in that randomization arm.
Interventions
- BEHAVIORAL Clinician Notification with Nurse Facilitation (CNNF)
- BEHAVIORAL Wait list control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2022-10-05 |
| Est. Completion | 2023-01-04 |
| Phase | NA |
What the finished NCT05563714 record still lists
NCT05563714 is an interventional study that assigns participants to a tested intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which Clinician Notification with Nurse Facilitation (CNNF) is the first listed.
NCT05563714 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05563714 about?
NCT05563714 is a clinical study titled "Anticoagulation With Enhanced Gastrointestinal Safety". This study is a pragmatic cluster randomized controlled trial to evaluate the effectiveness of a clinician-facing implementation strategy on the use of medication optimization (defined as either discontinuation of all antiplatelet therapy or initiation of and adherence to a proton pump inhibitor (PP...
What is the current status of trial NCT05563714?
This trial is currently completed. It is a NA study. The enrollment target is 341 participants. The study started on 2022-10-05. Estimated completion is 2023-01-04.
What interventions are being tested in trial NCT05563714?
The interventions under investigation include: Clinician Notification with Nurse Facilitation (CNNF) (BEHAVIORAL), Wait list control (BEHAVIORAL).
Who is sponsoring clinical trial NCT05563714?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05563714's enrollment target sits among peer trials
341 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06852170 · 341 participants · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI